Her defiance of Jim Crow laws in 1955 made her a star witness in a landmark segregation suit, but her act was overshadowed ...
The site, which will cost about €10.0 billion ($11.7 billion) to complete, will be the third-largest of the company’s Verbund ...
Keyboard shortcuts can supercharge your workflow - if you know what they are. Here are the ones I recommend to every user.
5d
Stafford’s late TD pass to Parkinson lifts the Rams past the Panthers 34-31 in tense playoff opener
Matthew Stafford threw a 19-yard go-ahead touchdown pass to Colby Parkinson with 38 seconds to lift the Los Angeles Rams to a ...
Tracy Letts’s eerily topical, decades-old play about a woman’s descent into a world of conspiracy theories makes its ...
Peter Krull, director of Earth Equity Advisors, discusses why he's bullish on renewable energy and shares his top clean ...
Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) is among the best fundamentally strong penny stocks to buy according to analysts. On December 19, TheFly reported that Cathie Wood’s ARK Investment has ...
Recursion Pharmaceuticals (RXRX) just delivered encouraging Phase 1b/2 TUPELO data for its FAP drug candidate REC-4881, and that clinical update has quickly reshaped how both Wall Street and ...
Cathie Wood’s ARK ETF published their daily trades for Friday, December 19th, 2025, showcasing significant activity in several key stocks. Leading the trades was a substantial sale of 23,110 shares of ...
Andrew Joseph covers health, medicine, and the biopharma industry in Europe. You can reach Andrew on Signal at drewqjoseph.71. LONDON — In the year-plus since Najat Khan joined the AI-focused drug ...
In this week’s edition of InnovationRx, we look at the biotech deal frenzy, Recursion’s incoming CEO, the infant formula botulism outbreak, and more. To get it in your inbox, subscribe here. Merck ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback